ArticlePreventive medicine2022
Centering equity in flavored tobacco ban policies: Implications for tobacco control researchers.
Article in Preventive medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.
- A systematic review investigating policy design and implementation of US state and local policy to restrict the sale of flavored tobacco products.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2026Pooled it
- An evaluation of Massachusetts' flavored tobacco restriction one year after policy implementation: Is it promoting equity?Journal of public health policy · 2026Article
- Restricting E-Cigarette Flavour Names to Reduce Youth Appeal: An Analysis of New Zealand's 2024 Regulations.Health promotion journal of Australia : official journal of Australian Association of Health Promotion Professionals · 2026Article
- "We're building the plane while we're flying it": perspectives on local cigar policy implementation from qualitative interviews with key personnel.Implementation science communications · 2026Article
- State-Level Flavored E-Cigarette Bans and Initiation Rates Among Youths and Adults.JAMA network open · 2026Article
- Unequal Impact of Flavored Tobacco Across Populations: From Neuroscience to Policy.Basic and clinical neuroscience · 2025Review
- National longitudinal risk of tobacco use among youth and young adults in US local jurisdictions with and without flavor and comprehensive smoke-free policies, 2014-2019.Journal of the National Cancer Institute. Monographs · 2025Article
- Recommendations for Centering Equity to Advance Federal and Local US Policies Regulating the Availability and Sale of Flavored Tobacco Products.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2025Article
- Factors associated with disposable electronic cigarette use among US youth: A national repeated cross-sectional study, 2021-22.Addiction (Abingdon, England) · 2025Observational
- Impact of Smoking Cessation Motivations and Barriers on Quit Intentions Following a Hypothetical Flavor Ban Among African American/Black Individuals Who Use Menthol Cigarettes: A Mixed-Methods Study.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2024Article
- What Will It Take to Achieve Equity in Policies Restricting Menthol and Other Flavored Nicotine and Commercial Tobacco Products?Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2024Article
- Examining the relationship of flavored tobacco product policy restrictions and flavored tobacco product use, among adolescents and young adults in the U.S.Preventive medicine · 2024Article
- A thematic content analysis of 2010-2015 state tobacco control legislation in the United States: Bill rationales and priority populations.Preventive medicine reports · 2023Article
- Impacts of Tax and Flavor Tobacco Policies on San Francisco Bay Area Tobacco Prices.Evaluation review · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 3 institutions in 1 country.
Funding
Abstract
To achieve equity in protection from poor health outcomes due to tobacco use, tobacco control policies and interventions need to affect socially disadvantaged groups more strongly than advantaged groups. Flavored tobacco bans have been seen as a policy with this potential. However, tobacco control researchers, in close concert with policy advocates, need to consider how to center equity throughout the policy process to achieve equitable outcomes from banning flavored tobacco. In this commentary, we outline the rationale for how and why tobacco control researchers should consider equity throughout the policy process to help fully achieve the potential of flavored tobacco ban policies. These recommendations emerged from a presentation at the Vermont Center on Behavior and Health 2021 Conference. Specifically, we focus on recommendations for tobacco control researchers to center equity including partnering with communities in agenda setting, examining how various policy formulations or exemptions may increase or decrease disparities, determining where flavor policies need to reach and whether policies are equitably reaching all populations disproportionately burdened by flavored tobacco, assessing whether policy implementation/enforcement is carried out equitably to maximize policy benefits, and evaluating policy impact with as much granularity as possible. Considering the entire policy process is central to enhancing equitable outcomes from banning flavored tobacco. Tobacco control researchers can play a key role in ensuring that these policies are viewed through an equity lens to, not just improve population health, but also to reduce harms to those disproportionately burdened by use of flavored products.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.